Specific populations tend to be more liable to the adverse effects of synthetic cannabinoids. People today with pre-existing psychiatric conditions, like schizophrenia and epilepsy, are at increased risk as a result of potential for SCs to precipitate psychiatric and neurologic Ailments. Additionally, the drug’s appeal to young demographics, spe